Radionuclide Therapy Tops AR-Pathway Inhibitor Switch for mCRPC Time to radiographic progression doubled with 177Lu-PSMA-617 Oct 25, 2023
Carbohydrates and Long-Term Weight Change; Value of Cardiac Transfers Also in TTHealthWatch: reducing infections in joint replacement Oct 21, 2023 podcast
Lonely Cancer Deaths; Virtual Reality for Pain; 3D Models May Improve Treatment News, features, and commentary about cancer-related issues Oct 19, 2023
Should Older Prostate Cancer Patients Jump Off the Active Surveillance Train? It's time for clear guidelines Oct 18, 2023
Hair Relaxers' Cancer Risk; Genetic Test Aids Rural Care; Drug Negotiation Fallout? News, features, and commentary about cancer-related issues Oct 13, 2023
SBRT Noninferior to Conventional RT for Intermediate-Risk Prostate Cancer Treatment over 1 to 2 weeks achieves similar outcomes to therapy given for as long as 7.5 weeks Oct 03, 2023
SBRT Added to Standard Tx Boosts Outcomes in Oligometastatic Prostate Cancer Combination improved biochemical response and PFS compared with systemic treatment alone Sep 27, 2023
TikTok Dinged for Misinformation; BRCA Risk Overestimated; Cheers for Oncology News, features, and commentary about cancer-related issues Sep 21, 2023
Cisplatin Shortage Eases; Air Pollution Linked to Breast Cancer; Pap Test Confusion News, features, and commentary about cancer-related issues Sep 15, 2023
Global Incidence of Early-Onset Cancer Has Surged Since 1990 Early-onset breast cancer has highest incidence and mortality rates Sep 06, 2023
Prostate Cancer Is Not Just an 'Old Man's Disease' Spreading this message can save lives Sep 02, 2023
Prayer to Cure Cancer; Exercise for Sexual Dysfunction; Carb Intake and Cancer News, features, and commentary about cancer-related issues Sep 01, 2023
Does Cancer Screening Actually Extend Lives? A series of articles look at whether the benefits for the few warrant the harms for the many Aug 28, 2023
Multi-Cancer Early Detection: 20th-Century Fiction Becomes Reality These tests could soon become a valuable addition to current cancer screening tools Aug 01, 2023
MR-Guided Adaptive SBRT Tied to Reduced Side Effects in Prostate Cancer However, this technique requires more time and resources than standard techniques Jul 24, 2023
Lumpers vs Splitters: Categorizing Prostate Cancer Should very low-risk and low-risk be combined into one? May 19, 2023
Drug Shortages Hit Oncology; Telemedicine Tops In-Person; Sniffing Out Lung Cancer News, features, and commentary about cancer-related issues May 12, 2023
Enzalutamide-ADT Cuts Risk for Disease Spread in Nonmetastatic Prostate Cancer Combo has potential to be new standard of care in patients with high-risk BCR, expert says Apr 30, 2023
FDA Panel Rejects Broad Olaparib Indication in Metastatic CRPC ODAC votes that olaparib-abiraterone combination should be restricted to BRCA-positive subset Apr 28, 2023
Talc-Cancer Lawsuits on Hold; Diet & Prostate Cancer; Active Surveillance Deep Dive News, features, and commentary about cancer-related issues Apr 21, 2023
Robust PSA Drops With Radionuclide Therapy in Castration-Resistant Prostate Cancer All but one patient had a PSA decline after a fractionated dose of 225Ac-J591 Apr 18, 2023
Older Men Still Overscreened for Prostate Cancer, Survey Says PSA screening rates over 50% for men 70 and up, despite USPSTF recommendations against it Apr 11, 2023
'Winners' and 'Losers'; Mandated Sick Leave and Cancer Screening; More AI Advances News, features, and commentary about cancer-related issues Mar 03, 2023
Cancer Drugs That Didn't Work; Another HIV Cure; Kiss of Success With Mistletoe News, features, and commentary about cancer-related issues Feb 24, 2023
Escalated ADT Falls Short in Men With High-Risk Features After Prostatectomy But add-on abiraterone and apalutamide may offer some benefits in those with higher PSA Feb 18, 2023
Add-On Olaparib Continues to Show Benefit in First-Line Treatment of mCRPC Final PROpel analysis also shows trend toward overall survival improvement with PARP inhibitor Feb 17, 2023
Adding Talazoparib to Enzalutamide Boosts PFS in Metastatic Prostate Cancer Combination achieved a 37% reduction in risk of progression, death versus ARPI alone Feb 17, 2023
Rucaparib Gets a Win in Metastatic Castration-Resistant Prostate Cancer Benefit in selected patients seen over physician's choice of docetaxel or second-generation ARPI Feb 16, 2023
If It Resembles Cancer but Doesn't Act Like Cancer, Is It Cancer? Physicians must consider patient perspectives on the Gleason 6 debate Feb 16, 2023
Short-Course Apalutamide to Reduce Active Surveillance Attrition in Prostate Cancer Editorialists question whether any intervention violates principles of surveillance Jan 17, 2023
MRI-Guided Focused Ultrasound Eases Pain From Bone Metastases More responses with ultrasound, but quality-of-life scores lower vs EBRT in nonrandomized trial Jan 11, 2023
MRI-Targeted Biopsy for Prostate Cancer Reduces Risk of Overdiagnosis Though at the cost of delayed diagnosis of some clinically significant cancers Dec 07, 2022
Can Oncologists Reduce the Suicide Risk in Their Prostate Cancer Patients? Barriers exist in identifying risk, but strategies are available Dec 06, 2022
Metastasis-Directed Therapy May Delay ADT in Advanced Prostate Cancer Surgery or radiation delayed initiation of systemic therapy by 18 months Nov 29, 2022
Primary Care Visits Prior to Cancer Diagnosis Tied to Lower Mortality Most benefit with annual visits, but even some use linked to better outcomes Nov 16, 2022
Could a Plant-Based Diet Benefit Men's Health Below the Belt? Analysis suggests protective nature of veggie-heavy diet in prostate cancer and more Oct 30, 2022
Good, and Safe, Results Tied to Oral Testosterone in Men With Deficiency Meta-analysis should spur more research on newer formulations, researcher says Oct 30, 2022
Metastasis-Directed Therapy for Prostate Cancer Increases PFS, Time off Hormones Radiotherapy led to "dramatic" slowing of progression, increased time with normal testosterone Oct 27, 2022
Sexual Health Not Part of Discussion for Women Undergoing Brachytherapy Much less likely than men to be queried about sexual function when receiving treatment Oct 25, 2022
Shorter Course of Radiation Therapy Proves Mettle in High-Risk Prostate Cancer Hypofractionation matches standard RT for survival and toxicity in a third less time Oct 25, 2022
